Civilization Ventures
Venture Capital
Active
San Francisco, United States
56
17M
39
8.00
1
0.30
2
- Stages of investment
- Areas of investment
Summary
The company was established in North America in United States. The main department of described VC is located in the San Francisco.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 deals per year. The top activity for fund was in 2019.
The fund was created by Shahram Seyedin-Noor.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Civilization Ventures, startups are often financed by U.S. Venture Partners (USVP), Designer Fund, The Vertical Group. The meaningful sponsors for the fund in investment in the same round are U.S. Venture Partners (USVP), Sanofi-Genzyme BioVentures, Norwest Venture Partners. In the next rounds fund is usually obtained by IndieBio, Wellington Management, U.S. Venture Partners (USVP).
Besides, a startup needs to be aged 2-3 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the most successful fund investment fields, there are Biopharma, Artificial Intelligence. Among the most popular portfolio startups of the fund, we may highlight Omada Health, Ulab Systems, CATALOG.
Investor highlights
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- USD 35000000
- Fund raised date
- 2020-08-25
Analytics
- Total investments
- 56
- Lead investments
- 1
- Exits
- 2
- Rounds per year
- 8.00
- Follow on index
- 0.30
- Investments by industry
- Biotechnology (36)
- Health Care (31)
- Medical (19)
- Life Science (12)
- Therapeutics (9) Show 34 more
- Investments by region
-
- United States (47)
- United Kingdom (4)
- Brazil (1)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 5
- Avg. valuation at time of investment
- 20M
- Group Appearance index
- 0.88
- Avg. company exit year
- 5
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Axonis | 14 Jul 2021 | Biotechnology, Medical | Seed | 5M | United States, Massachusetts, Cambridge |
| Outpace Bio | 23 Mar 2023 | Biotechnology, Health Care, Life Science, Pharmaceutical | Early Stage Venture | 25M | United States, Washington, Seattle |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.